BIM
AGRX

BlackRock Investment Management’s Agile Therapeutics AGRX Stock Holding History

BlackRock Investment Management’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$260K Hold
23
– – ﹤0.01% 3194
2016
Q3 		$318K Hold
23
– – ﹤0.01% 3173
2016
Q2 		$346K Buy
23
+2
+10% +$27.4K ﹤0.01% 3194
2016
Q1 		$258K Buy
21
+3
+17% +$38.7K ﹤0.01% 3109
2015
Q4 		$357K Hold
18
– – ﹤0.01% 3118
2015
Q3 		$245K Hold
18
– – ﹤0.01% 3207
2015
Q2 		$317K Buy
18
+17
+1,700% +$363K ﹤0.01% 3217
2015
Q1 		$14K Hold
1
– – ﹤0.01% 3544
2014
Q4 		$9K Hold
1
– – ﹤0.01% 3724
2014
Q3 		$11K Hold
1
– – ﹤0.01% 3641
2014
Q2 		$13K Buy
+1
New +$14.5K ﹤0.01% 3547

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock Investment Management's AGRX Position: Q4 2016 in Review

BlackRock Investment Management held its Agile Therapeutics (AGRX) position steady in Q4 2016 at 23 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #3194.

BlackRock Investment Management first reported a position in AGRX in Q2 2014 and has held it in 11 quarters since. The position peaked at $357K in Q4 2015. 62 funds tracked by Wall St. Rank hold AGRX as of Q4 2016.

  • BlackRock Investment Management held 23 shares of Agile Therapeutics worth $260K as of Q4 2016.
  • BlackRock Investment Management left its Agile Therapeutics share count unchanged in Q4 2016.
  • Agile Therapeutics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3194 holding.
  • BlackRock Investment Management first reported a position in Agile Therapeutics in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Investment Management's Agile Therapeutics position peaked at $357K in Q4 2015.
  • 62 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.